ORIC Pharmaceuticals, Inc.
ORIC Pharmaceuticals, Inc.（ORIC）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
oric · 股价预测 · 10 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 10 位华尔街分析师
Buy
10 位分析师
共识
评级分布
12 个月目标价
High
$25.00
Consensus
$19.25
+154.8% upside
Low
$15.00
Median: $18.5 · Last Close: $7.55
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$19.25
154.8% upside
High Target
$25
230.9%
Low Target
$15
98.5%
Current Price
$7.55
as of today
Based on analyst price targets, the ORIC stock price prediction for the next 12 months ranges from $15 to $25. The consensus ORIC price forecast of $19.25 implies 154.8% upside from the current price of $7.55.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $7.20 | ↓ 4.76% |
1-day model range: $7.14–$7.25. Peak: $7.25 (-4.76%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ORIC · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-05 | Citigroup | Maintains | Buy→Buy |
| 2026-04-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-01 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-24 | Wedbush | Maintains | Outperform→Outperform |
| 2026-02-24 | Citigroup | Maintains | Buy→Buy |
| 2026-01-13 | Wedbush | Maintains | Outperform→Outperform |
| 2025-12-08 | Wedbush | Maintains | Outperform→Outperform |
| 2025-12-08 | Wells Fargo | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on ORIC Pharmaceuticals, Inc. (ORIC) stock. Of the recent 76 rating actions, 3 were upgrades and 5 were downgrades. 10 analysts currently cover ORIC.
分析师推荐趋势
ORIC analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$8M
↓ 24.1% YoY
Revenue Next Year
$2M
↓ 73.1% YoY
EPS This Year
$-1.45
EPS Next Year
$-1.54
↑ 6.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast ORIC EPS of $-1.45 for the current fiscal year, based on estimates from 11 analysts. The ORIC revenue forecast is $8M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ORIC 股价预测由两类独立数据源支撑：来自 10 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ORIC 的共识目标价为 $19.25（+154.8% 上行空间），分析师共识为 Buy。
ORIC 的短期预测（明日）为 $7.20（-4.76%）。
ORIC Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 ORIC。ORIC 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
ORIC 预测 · 8 个问题根据 10 位华尔街分析师，ORIC 的 12 个月平均目标价为 $19.25，最高 $25.00、最低 $15.00。若有图表，中位目标价可在上方查看。相对当前价 $7.55，隐含约 +154.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.